Biolegend, Inc.

BioLegend is a biomedical research company specializing in the development and manufacturing of research reagents and antibodies for scientific investigations. The company operates a modern manufacturing facility in San Diego, California, and offers a comprehensive portfolio including monoclonal and polyclonal antibodies, immunoassay solutions, recombinant proteins, magnetic cell separation products, and single-cell proteogenomics reagents. BioLegend serves research institutions, pharmaceutical companies, and clinical laboratories across multiple therapeutic areas including neuroscience, oncology, immunology, stem cell research, and clinical diagnostics. The company has acquired the Covance antibody product portfolio to strengthen its neuroscience offerings and collaborates with leading research organizations such as The Michael J. Fox Foundation for Parkinson's Research and Illumina. BioLegend provides IVD (in vitro diagnostic) reagents and ASR (Analyte Specific Reagent) products for immunohistochemistry, immunophenotyping, and flow cytometry applications. The company emphasizes quality manufacturing, expert technical support, and custom product development services to support precision medicine, oncology, and biomedical discovery.